Website
-
Press Releases | NLS-1 Pharma
https://nlspharma.com/news/press-releases/NLS-1 Pharma unveils positive phase 2 data for NLS-1 (Mazindol CR) in adults with ADHD, demonstrating significant improvement in symptoms
-
Awards | NLS-1 Pharma
https://nlspharma.com/news/awards/CEO of NLS-1 Pharma AG is honored with Several Illustrious Awards This Summer
-
Industry Partnerships | NLS-1 Pharma
https://nlspharma.com/partnering/industry-partnerships/NLS’s business strategy focuses on new approaches to treat mental and behavioral disorders, and to enhance cognitive function in healthy people at a pre-clinical
Erkannte Technologien auf dieser Website
CMS:
Analytics:
Programming Languages:
Databases:
Font Scripts:
JavaScript Libraries:
Maps:
Miscellaneous:
Video Players:
Web Frameworks:
Web Servers:
Widgets:
Analysiert am: 10/02/2019
